Wednesday, June 9, 2010

National Taiwan University_ Factor 9 treatment on Hemophilia type B patient

2010, Jun., 10 Taiwan National pharmaceutical & Biotech project announced sponsored technology regarding engineered high potent (rather than long circulation) factor 9 for treatment of hemophilia.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)
alveice Team. Powered by Blogger.